Sierra Oncology, Inc. (SRRA) stock price, quote, history ... Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks Investment Research Upgrades Sierra Oncology (NASDAQ ... Sierra Oncology (NASDAQ:SRRA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The brokerage presently
Get the latest Sierra Oncology, Inc. (SRRA) stock news and headlines to help you in your trading and investment decisions.
Stock News - TD Ameritrade Company profile. Sierra Oncology, Inc. is late stage drug development company. The Company is focused on advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology. SHIP Seanergy Maritime Holdings Corp. — Stock Price and ... Seanergy Maritime Holdings Corp. SHIP 0.22 0.01 (5.72%). NASDAQ Updated Jun 9, 2020 8:05 AM
Find real-time SRRA - Sierra Oncology Inc stock quotes, company profile, news and forecasts from CNN Business.
Isoray Inc Stock Quote: ISR Stock News, Quotes, Analysis ... ISR, Isoray Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines SRRA - Ownership Information for SIERRA ONCOLOGY, INC ... View institutional stock ownership, mutual fund ownership, and top individual ownership of SIERRA ONCOLOGY, INC. (SRRA). msn back to msn home money. powered by Invesco Zacks Micro Cap ETF Sierra Oncology Inc (NASDAQ:SRRA) Given $74.00 Consensus ...
SRRA Stock Price | Sierra Oncology Inc. Stock Quote (U.S ...
SRRA: Sierra Oncology Inc Detailed Estimate. Get the latest Detailed Estimate from Zacks Investment Research. SRRA: Sierra Oncology Inc - Interactive Chart Chart. Get the latest Interactive Chart for Sierra Oncology Inc from Zacks Investment Research Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. SRRA stock was acquired by a variety of institutional investors in the last quarter, including Vivo Capital LLC, Orbimed Advisors LLC, Abingworth LLP, and VR Adviser LLC. Company insiders that have bought Sierra Oncology stock in the last two years include Andrew R Allen, and Barbara Klencke. SRRA | Complete Sierra Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Zacks Investment Research is a leading provider of independent investment research with a proven track record of outperforming the market. The content for this
SRRA Split History